Lam Research (NASDAQ:LRCX – Free Report) had its price objective lifted by Needham & Company LLC from $900.00 to $1,030.00 in a research note published on Thursday morning, MarketBeat.com reports. The firm currently has a buy rating on the semiconductor company’s stock. A number of other research analysts have also recently commented on the company. […]
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a note issued to investors on Friday, Benzinga reports. They presently have a $26.00 price target on the stock. Needham & Company LLC’s price objective suggests a potential upside of 188.89% from the […]
Needham & Company LLC reaffirmed their buy rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $32.00 target price on the biopharmaceutical company’s stock. Several other brokerages have also issued reports on ACAD. HC Wainwright reissued a buy rating and issued […]
I-Mab (NASDAQ:IMAB – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Needham & Company LLC in a research report issued on Friday, Benzinga reports. They currently have a $6.00 target price on the stock. Needham & Company LLC’s price objective suggests a potential upside of 231.49% from the stock’s previous […]
Needham & Company LLC reaffirmed their buy rating on shares of Harmonic (NASDAQ:HLIT – Free Report) in a report published on Tuesday, Benzinga reports. They currently have a $18.00 price target on the communications equipment provider’s stock. A number of other analysts also recently commented on the stock. TheStreet upgraded shares of Harmonic from a […]